Madhvi Menon serves as Group Leader at the University of Manchester, where she investigates the complex interactions between tissue-infiltrating B cells and their microenvironment in chronic respiratory disease and autoimmunity. Her research has uncovered critical mechanisms driving inflammation and immune dysfunction, directly informing new therapeutic strategies for conditions that affect hundreds of millions worldwide.
As Immunoverse Program Lead, Dr. Menon brings both scientific rigor and a deep commitment to patient impact. The Immunoverse program aims to create comprehensive maps of immune health and dysfunction, translating the complex language of immune cell signaling into the actionable coordinates needed for early detection and intervention in immune-mediated diseases. Her expertise bridges high-dimensional immune profiling and the clinical decisions that depend on it, ensuring that Cytognosis captures the full complexity of human immune biology.